An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Several professionals said the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, legal action or prison.
Platform Reaction and Content Elimination
Based on the social media company, the service has taken down violative material and prohibited related hashtags and search suggestions. The organization said it was dedicated to keeping the platform secure and investing in enhancing compliance measures.
Digital Trading Activities
Research also discovered groups with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of users, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
After moments of entering one community, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Product Details and Pricing
Inside these communities, posts show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram said it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Even if the science behind this drug is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly significant health risks”.
